What requirement did the Combat Methamphetamine Act of 2005 enforce?

The Combat Methamphetamine Act of 2005 was established to address the increasing problem of methamphetamine production and abuse. One of its key requirements is that it limits the quantity of certain over-the-counter (BTC) medications containing pseudoephedrine and similar substances that individuals can purchase at one time. This limitation aims to make it more difficult to acquire the raw materials necessary for the illicit production of methamphetamine. By controlling the quantity purchased, the legislation helps mitigate the risk of these substances being diverted for illegal drug manufacturing while still allowing consumers access to necessary medications.

The other options either imply a broader regulatory approach that was not enacted by this specific legislation or suggest alterations in access and pricing that do not align with the actual provisions of the Combat Methamphetamine Act.